T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Napco Security Technologies
NSSC
$1.39B
| $1.06M | ﹤0.01% |
25,291
+985
| +4% | +$41.4K |
|
2052
Cannae Holdings
CNNE
$675M
| $1.05M | ﹤0.01% |
67,059
+7,969
| +13% | +$136K |
|
2053
Talos Energy
TALO
$2.58B
| $1.05M | ﹤0.01% |
95,616
+15,126
| +19% | +$158K |
|
2054
Upbound Group
UPBD
$1.15B
| $1.05M | ﹤0.01% |
59,958
+2,259
| +4% | +$43.7K |
|
2055
Origin Bancorp
OBK
$1.67B
| $1.05M | ﹤0.01% |
27,914
+1,239
| +5% | +$44.4K |
|
|
RWT
2056
Redwood Trust
RWT
$599M
| $1.05M | ﹤0.01% |
189,828
+17,953
| +10% | +$98.7K |
|
2057
Astrana Health
ASTH
$1.78B
| $1.05M | ﹤0.01% |
42,258
+1,562
| +4% | +$41.5K |
|
|
PRSU
2058
Pursuit Attractions and Hospitality Inc
PRSU
$1.27B
| $1.05M | ﹤0.01% |
31,124
+4,900
| +19% | +$171K |
|
2059
Ceco Environmental
CECO
$4.5B
| $1.04M | ﹤0.01% |
17,387
+1,510
| +10% | +$80.8K |
|
2060
Burford Capital
BUR
$968M
| $1.04M | ﹤0.01% |
116,495
+8,731
| +8% | +$85.5K |
|
2061
PagerDuty
PD
$932M
| $1.04M | ﹤0.01% |
78,999
-19,479
| -20% | -$284K |
|
2062
West Bancorporation
WTBA
$511M
| $1.03M | ﹤0.01% |
46,607
+1,366
| +3% | +$29.5K |
|
2063
US Physical Therapy
USPH
$1.22B
| $1.02M | ﹤0.01% |
13,124
+1,192
| +10% | +$96.7K |
|
2064
Heritage Financial
HFWA
$1.22B
| $1.02M | ﹤0.01% |
43,248
+3,638
| +9% | +$85.7K |
|
2065
Ibotta
IBTA
$769M
| $1.02M | ﹤0.01% |
44,967
+1,709
| +4% | +$46.1K |
|
2066
Newell Brands
NWL
$2.63B
| $1.02M | ﹤0.01% |
274,537
-45,416
| -14% | -$183K |
|
2067
Community Trust Bancorp
CTBI
$1.44B
| $1.02M | ﹤0.01% |
18,061
-1,482
| -8% | -$81.9K |
|
|
KE
2068
Kimball Electronics
KE
$606M
| $1.02M | ﹤0.01% |
36,493
-2,801
| -7% | -$80.8K |
|
2069
PagSeguro Digital
PAGS
$2.43B
| $1M | ﹤0.01% |
104,085
+5,612
| +6% | +$53.8K |
|
2070
nLIGHT
LASR
$2.9B
| $997K | ﹤0.01% |
26,574
+422
| +2% | +$14.1K |
|
2071
CRA International
CRAI
$1.07B
| $993K | ﹤0.01% |
4,946
-296
| -6% | -$55.8K |
|
2072
Clarivate
CLVT
$1.25B
| $991K | ﹤0.01% |
296,652
-93,431
| -24% | -$332K |
|
2073
Amphastar Pharmaceuticals
AMPH
$858M
| $986K | ﹤0.01% |
36,796
-238,426
| -87% | -$6.14M |
|
|
CTO
2074
CTO Realty Growth
CTO
$819M
| $985K | ﹤0.01% |
53,463
+2,474
| +5% | +$42.3K |
|
2075
Freedom Holding
FRHC
$9.65B
| $984K | ﹤0.01% |
8,085
+636
| +9% | +$92.2K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.